Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MOXIFLOXACIN HYDROCHLORIDE USP (NON STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 24371.
Remarkably, this DMF maintains an Active status since its submission on November 25, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2013, and payment made on September 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II